Details of the Drug Metabolized by Drug-Metabolizing Enzyme (DME)
| General Information of Drug (ID: DR0278) | ||||||
|---|---|---|---|---|---|---|
| Drug Name |
Carmustine
|
|||||
| Synonyms |
Carmubris; Carmustin; Carmustina; Carmustina [INN-Spanish]; Carmustinum; Carmustinum [INN-Latin]; DTI 015; Gliadel; Becenum; Becenun; Bi CNU; BiCNU (TN); Bis(2-chloroethyl)nitrosourea; Bischlorethylnitrosourea; Bischlorethylnitrosurea; Bischloroethyl nitrosourea; Bischloroethylnitrosourea; Gliadel Wafer; Nitrumon; SRI 1720; carmustine; 1,3-Bis(2-chloroethyl)-1-nitrosourea; 1,3-Bis(2-chloroethyl)nitrosourea; 154-93-8; BCNU; BiCNU; FDA 0345; N,N'-BIS(2-CHLOROETHYL)-N-NITROSOUREA; NCI-C04773; Urea, N,N'-bis(2-chloroethyl)-N-nitroso-
|
|||||
| Indication | Hepatocellular carcinoma [ICD11: 2C12] | Approved | [1] | |||
| Structure |
![]() |
|||||
| 3D MOL | 2D MOL | |||||
| Pharmaceutical Properties | Molecular Weight | 214.05 | Topological Polar Surface Area | 61.8 | ||
| Heavy Atom Count | 12 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | |||
| Cross-matching ID | ||||||
| The Metabolic Roadmap of This Drug | |||||
|---|---|---|---|---|---|
| The Full List of Drug Metabolites (DM) of This Drug | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
| The Full List of Metabolic Reaction (MR) of This Drug | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||
| Drug-Metabolizing Enzyme(s) (DME) Metabolizing This Drug | ||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
||||||||||||||||||||||||||||||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.


